It was reported that the expression of mutp53 in human lung cancer correlates with increased PD-L1 expression, which may help to identify patients responsive to checkpoint inhibitors targeting PD-L1 (Dong et al., 2017). The gene discussed is CD274; the disease is lung cancer.